SXTP
60 DEGREES PHARMACEUTICALS, INC.Company Information
- Company Name
- 60 DEGREES PHARMACEUTICALS, INC.
- CIK
- CIK0001946563
- Category
- <br>Emerging growth company
- Ticker: Exchange
- SXTP: Nasdaq, SXTPW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- SXTP
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-12
- Last sale
- —
- Shares purchased (TTM)
- 20,633
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 349,321
- Shares outstanding
- 2,653,848
- Ownership
- 13.16%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -23.10%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | - | - | - | - | - | - | - | - | - | - | 2 | 2 | ||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 3 | 2 | 4 | 2 | 3 | 2 | 3 | 2 | 3 | 2 | 2 | ||||||
| Accounts Receivable Net Current | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Prepaid Expense Current | - | - | - | - | - | - | - | - | - | - | 4 | 6 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 4 | - | ||||||
| Deferred Offering Costs | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Short Term Investments | - | - | 1 | 0 | 0 | - | 2 | 2 | - | - | - | - | ||||||
| Inventory Net | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Assets Current | 4 | 6 | 5 | 6 | 4 | 6 | 5 | 7 | 4 | 8 | 7 | 9 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Assets Noncurrent | ||||||||||||||||||
| Prepaid Expense Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Other Assets | ||||||||||||||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 4 | 7 | 5 | 7 | 4 | 6 | 6 | 7 | 4 | 8 | 8 | 9 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Secured Debt Current | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 2 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Secured Long Term Debt | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 3 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 45 | 45 | 42 | 41 | 37 | 37 | 35 | 35 | 29 | 29 | 27 | 27 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -52 | -50 | -48 | -46 | -44 | -42 | -41 | -38 | -36 | -32 | -33 | -31 | ||||||
| Stockholders Equity | 3 | 5 | 3 | 4 | 2 | 4 | 4 | 6 | 3 | 7 | 5 | 7 | ||||||
| Minority Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 4 | 7 | 5 | 7 | 4 | 6 | 6 | 7 | 4 | 8 | 8 | 9 | ||||||
| Series A Preferred Stock | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | - | ||||||
| Common Class A | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Common Stock Shares Issued | 3 | 3 | 1 | 4 | 1 | 1 | 0 | 2 | 1 | 12 | 0 | - | ||||||
| Shares Outstanding | 3 | 3 | 1 | 4 | 1 | 7 | 0 | 2 | 1 | 12 | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | - | - | 1 | 1 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trial60 DEGREES PHARMACEUTICALS, INC. (SXTP) — SEC Financial Statements & Analysis
60 DEGREES PHARMACEUTICALS, INC. (SXTP) is a pharmaceutical preparations company, incorporated in DE. 60 DEGREES PHARMACEUTICALS, INC. trades on Nasdaq as: SXTP, SXTPW. 60 DEGREES PHARMACEUTICALS, INC. (SXTP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, 60 DEGREES PHARMACEUTICALS, INC. carries a market cap of $4.67M, a P/E ratio of -0.54x, a P/B ratio of 1.85x, a P/S ratio of 4.20x, an enterprise value of $3.65M, and an EV/EBITDA multiple of -0.43x. On profitability, it posts a gross margin of 19.42%, an operating margin of -774.76%, a net margin of -775.24%, a Return on Equity (ROE) of -353.41%, a Return on Assets (ROA) of -203.50%, and a Return on Invested Capital (ROIC) of -896.60%. Per share, it reports EPS of $-3.25, diluted EPS of $-3.25, free cash flow per share of $-3.37, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 73.21% year-over-year, net income growth of 11.89% year-over-year, and EPS growth of -84.47% year-over-year. On the balance sheet, it maintains a current ratio of 2.32x, a quick ratio of 0.99x, working capital of $2.13M, a debt-to-equity ratio of 0.69x, a debt ratio of 0.41, an interest coverage ratio of -1134.64x, free cash flow of $-8.95M (TTM), and net debt of $-1.02M. Figures sourced from SEC EDGAR.
- Market Cap
- $4.67M
- P/E TTM
- -0.54x
- EPS TTM
- $-3.25
- P/B TTM
- 1.85x
- ROE TTM
- -353.41%
- ROA TTM
- -203.50%
- Debt To Equity
- 0.69x
- Free Cash Flow TTM
- $-8.95M
- Net Revenue TTM Growth 1Y
- 73.21%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is 60 DEGREES PHARMACEUTICALS, INC. in?
60 DEGREES PHARMACEUTICALS, INC. (SXTP) operates in the Pharmaceutical Preparations industry.
What exchange does SXTP trade on?
60 DEGREES PHARMACEUTICALS, INC. (SXTP) trades on the Nasdaq.
Where is 60 DEGREES PHARMACEUTICALS, INC. incorporated?
60 DEGREES PHARMACEUTICALS, INC. is incorporated in DE.
When was 60 DEGREES PHARMACEUTICALS, INC. (SXTP)'s most recent SEC filing?
60 DEGREES PHARMACEUTICALS, INC. (SXTP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is SXTP's market cap?
60 DEGREES PHARMACEUTICALS, INC. (SXTP) has a market capitalization of $4.67M as of 2026-06-30.
What is SXTP's EPS (earnings per share)?
60 DEGREES PHARMACEUTICALS, INC. (SXTP)'s trailing twelve month EPS is $-3.25 as of 2026-06-30.
What is SXTP's ROE (return on equity)?
60 DEGREES PHARMACEUTICALS, INC. (SXTP)'s trailing twelve month Return on Equity (ROE) is -353.41% as of 2026-06-30.
What is SXTP's ROA (return on assets)?
60 DEGREES PHARMACEUTICALS, INC. (SXTP)'s trailing twelve month Return on Assets (ROA) is -203.50% as of 2026-06-30.
What is SXTP's ROIC (return on invested capital)?
60 DEGREES PHARMACEUTICALS, INC. (SXTP)'s trailing twelve month Return on Invested Capital (ROIC) is -896.60% as of 2026-06-30.
What is SXTP's EV/EBITDA?
60 DEGREES PHARMACEUTICALS, INC. (SXTP)'s trailing twelve month EV/EBITDA is -0.43x as of 2026-06-30.